KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 152 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,633,000 | -9.3% | 1,068,719 | +0.3% | 1.50% | -25.5% |
| Q2 2018 | $4,007,000 | +57.7% | 1,065,801 | +71.5% | 2.01% | +37.4% |
| Q1 2018 | $2,541,000 | -12.1% | 621,386 | -0.0% | 1.46% | -11.0% |
| Q4 2017 | $2,890,000 | -42.7% | 621,574 | -12.6% | 1.65% | -37.9% |
| Q3 2017 | $5,047,000 | -11.2% | 710,912 | -9.5% | 2.65% | -12.6% |
| Q2 2017 | $5,681,000 | +11.3% | 785,836 | -5.2% | 3.03% | +11.8% |
| Q1 2017 | $5,106,000 | +315.8% | 828,914 | +295.4% | 2.71% | +261.5% |
| Q4 2016 | $1,228,000 | +69.8% | 209,629 | +53.9% | 0.75% | +42.6% |
| Q3 2016 | $723,000 | -13.4% | 136,224 | +7.9% | 0.53% | -13.8% |
| Q2 2016 | $835,000 | +40.3% | 126,230 | -1.1% | 0.61% | +22.5% |
| Q1 2016 | $595,000 | +90.7% | 127,620 | +106.1% | 0.50% | +76.6% |
| Q4 2015 | $312,000 | +14.7% | 61,919 | -20.0% | 0.28% | +36.2% |
| Q3 2015 | $272,000 | -65.8% | 77,404 | -2.8% | 0.21% | -62.6% |
| Q2 2015 | $795,000 | +44.3% | 79,667 | +83.8% | 0.55% | +49.1% |
| Q1 2015 | $551,000 | +101.1% | 43,341 | +123.2% | 0.37% | +119.5% |
| Q4 2014 | $274,000 | +5.0% | 19,416 | +2.2% | 0.17% | +3.0% |
| Q3 2014 | $261,000 | – | 18,998 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |